CX1739
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CX1739, covering 2016-07-28 to 2016-07-28. Get the full timeline:
Most recent: Clinical Trial Update: Antagonism of Opioid-Induced Respiratory Depression by CX1739 With Preservation of Opioid Analgesia [Phase 2]